Placental Cytokines and the Pathogenesis of Preeclampsia
Tóm tắt
The authors explore the hypothesis that tumor necrosis factor‐α (TNF‐α) and possibly other inflammatory cytokines are overproduced by the placenta in response to local ischemia/hypoxia contributing to increased plasma levels, and subsequent endothelial activation and dysfunction in the pregnancy disorder, preeclampsia. It is widely held that inadequate trophoblast invasion and physiologic remodeling of spiral arteries initiate placental ischemia/hypoxia in preeclampsia. Furthermore, focal areas of placental hypoxia have been implicated in the production of “toxic” factor(s) by the placenta, which circulate and cause maternal disease. Placental trophoblast cells and fetoplacental macrophages normally produce TNF‐α and in‐terleukin‐1 (IL‐1), which are capable of producing endothelial cell activation and dysfunction. Hypoxia has recently been reported to increase TNF‐α and IL‐1 production by term villous explants from the human placenta. Placental cells also express erythropoietin (EPO), which is the prototype molecule for transcriptional regulation by hypoxia in mammals. Interestingly, TNF‐α and IL‐1 have DNA sequences homologous or nearly homologous to the hypoxia‐responsive enhancer element of the EPO gene, thus providing a potential, but as of yet, untested molecular link between placental hypoxia and stimulation of cytokine production. Inflammatory cytokines overproduced by the placenta in response to hypoxia may then lead to increased plasma levels and endothelial activation and dysfunction in preeclampsia. The purpose of this short review is to critically evaluate the hypothesis that placental cytokines contribute to the pathogenesis of preeclampsia. Of note, the etiology of the disease presumably related to deficient trophoblast invasion is beyond the scope of this work.
Từ khóa
Tài liệu tham khảo
Deng L., 1994, Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia, Obstet Gynecol, 84, 941
Conrad KP, 1995, Nitric oxide biosynthesis in normal and preeclamptic pregnancy: A preliminary report, J Am Soc Nephrol, 6, 657
MayerA.Changes of the endothelium during eclampsia and their significance.Klinische Wochenzeitschrift1924;H27.
Cotran RS, 1990, Cytokine‐endothelial interactions in inflammation, immunity, and vascular injury, J Am Soc Nephrol, 1, 225, 10.1681/ASN.V13225
Hinsbergh VWM, 1988, Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and rats in vivo, Blood, 72, 1467, 10.1182/blood.V72.5.1467.1467
Estelles A., 1994, Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation, Blood, 84, 143, 10.1182/blood.V84.1.143.143
Wang P., 1994, Administration of tumor necrosis factor‐α in vivo depresses endothelium‐dependent relaxation, Am J Physiol, 266, H2535
Keith JC, 1993, Letter to the Editor, J Perinatol, 417
Khong TY, 1982, Immunological Obstetrics, 492
Kupferminc MJ, 1994, Tumor necrosis factor‐α is elevated in plasma and amniotic fluid of patients with severe preeclampsia, Am J Obstet Gynecol, 170, 1752, 10.1016/S0002-9378(12)91845-1
Greer IA, 1994, Increased concentrations of cytokines inerleukin‐6 and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction, Obstet Gynecol, 84, 937
PrietoJP BenyoDF MilesTM ConradKP.Human ‘de novo’ endothelium is activated by TNF‐α concentrations relevant to preeclampsia. 10th World Congress International Society for the Study of Hypertension in Pregnancy. August1996.
Saks S., 1992, Recombinant human TNF‐alpha: Preclinical studies and results from early clinical trials, Immunol Ser, 56, 567
Smart SJ, 1994, TNF‐α‐induced transendothelial neutrophil migration is IL‐8 dependent, Am J Physiol, 266, L238
Tracey KJ., 1994, The Cytokine Handbook, 289
Paulesu L., 1991, Immunohistochemical localization of IL‐1α and IL‐1β in normal human placenta, Lymph Cyto Res, 10, 443
Baergen R., 1994, Cytokine expression in the placenta: The role of interleukin 1 and interleukin 1 receptor antagonist expression in chorioamnionitis and parturition, Arch Pathol Lab Med, 118, 52
Chen HL, 1991, Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation, Am J Pathol, 139, 327
Yang Y., 1993, Molecular, biochemical, and functional characteristics of tumor necrosis factor‐α produced by human placental cytotrophoblastic cells, J Immunol, 150, 5614, 10.4049/jimmunol.150.12.5614
Hanretty KP, 1990, Progress In Obstetrics and Gynaecology, 33
Soma H., 1982, Morphologic changes in the hypertensive placenta, Contrib Gynec Obstet, 9, 58, 10.1159/000406845
Tominaga T., 1996, Accomodation of the human placenta to hypoxia, Am J Obstet Gynecol, 94, 679, 10.1016/0002-9378(66)90401-7
Erslev AJ, 1991, Erythropoietin: Molecular, Cellular, and Clinical Biology
Benyo DF, Hypoxia stimulates cytokineproduction by villous explants from the human placenta, J. Clin. Endocrinol. Metabl.